文献速递神经肿瘤

直径大于3厘米的大型前庭神经鞘瘤的伽玛刀放射外科治疗

Gamma Knife radiosurgery for large vestibular schwannomas greater than 3 cm in diameter.
PubMed 文献 · J Neurosurg · 2017-07-14

该研究回顾2000至2014年35例单维度大于3厘米且体积大于10立方厘米的大型前庭神经鞘瘤患者接受伽玛刀放射外科治疗的经验,中位随访48个月,57.1%的肿瘤体积缩小超过50%,肿瘤体积大于等于15立方厘米是预测治疗失败的重要因素。

要点

  • 大型前庭神经鞘瘤(单维度大于3厘米且体积大于10立方厘米)接受伽玛刀放射外科治疗,中位随访48个月,57.1%的肿瘤体积缩小超过50%。
  • 肿瘤体积大于等于15立方厘米是预测伽玛刀放射外科治疗失败的显著因素(p=0.005)。
  • 伽玛刀放射外科治疗后肿瘤增大与后续切除的关系呈 borderline 统计学意义(p=0.05,HR 9.97,CI 0.99-100.00)。

核心结论

  • 尽管显微外科切除仍是前庭神经鞘瘤的主要治疗选择,但多数单维度大于3厘米且体积大于10立方厘米、占位效应可耐受的前庭神经鞘瘤可通过伽玛刀放射外科治疗获得满意管理。
  • 肿瘤体积大于等于15立方厘米是预测伽玛刀放射外科治疗后肿瘤控制不佳的显著因素。

研究设计与样本

  • 回顾性分析2000年至2014年间35例接受伽玛刀放射外科治疗的大型前庭神经鞘瘤患者,大型定义为单维度大于3厘米且体积大于10立方厘米。
  • 9例(25.7%)患者既往接受过切除术。
  • 中位总覆盖体积为14.8立方厘米(范围10.3-24.5立方厘米),中位肿瘤边缘剂量为11 Gy(范围10-12 Gy)。

主要发现

  • 中位随访48个月(范围6-156个月),所有35例患者均有定期MRI随访。
  • 20例肿瘤(57.1%)体积缩小超过50%,5例(14.3%)体积缩小15%-50%,5例(14.3%)大小稳定(体积变化小于15%),5例(14.3%)体积增大(这些病灶最终均被切除)。
  • 4例患者(11.4%)因症状进展在9个月至6年内接受切除术;1例患者(2.9%)因新发难治性三叉神经痛在伽玛刀放射外科治疗后48个月接受开放手术;2例患者(5.7%)出现症状性囊肿并接受囊肿-腹腔分流术。
  • 伽玛刀放射外科治疗前存在三叉神经感觉功能障碍的12例患者中,8例(66%)感觉减退缓解;1例面肌痉挛在治疗后3年完全缓解;7例面肌无力患者治疗后无恶化;治疗前有可用听力的3例患者中2例听力下降、1例保持相同水平;2例患者从重度听力损失改善至纯音测听小于50 dB。
  • 伽玛刀放射外科治疗后肿瘤增大与后续切除的关系呈 borderline 统计学意义(p=0.05,HR 9.97,CI 0.99-100.00);肿瘤体积大于等于15立方厘米是预测伽玛刀放射外科治疗失败的显著因素(p=0.005);基于伽玛刀放射外科治疗指征的结果差异无统计学意义(p=0.0761)。

关键数值与推荐

  • 大型前庭神经鞘瘤定义为单维度大于3厘米且体积大于10立方厘米。
  • 肿瘤体积大于等于15立方厘米是预测伽玛刀放射外科治疗失败的显著因素(p=0.005)。
  • 伽玛刀放射外科治疗后肿瘤增大与后续切除的关系:p=0.05,HR 9.97,CI 0.99-100.00。
  • 基于伽玛刀放射外科治疗指征的结果差异无统计学意义(p=0.0761)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Stereotactic radiosurgery (SRS) is an important alternative management option for patients with small- and medium-sized vestibular schwannomas (VSs). Its use in the treatment of large tumors, however, is still being debated. The authors reviewed their recent experience to assess the potential role of SRS in larger-sized VSs. METHODS Between 2000 and 2014, 35 patients with large VSs, defined as having both a single dimension > 3 cm and a volume > 10 cm3, underwent Gamma Knife radiosurgery (GKRS). Nine patients (25.7%) had previously undergone resection. The median total volume covered in this group of patients was 14.8 cm3 (range 10.3-24.5 cm3). The median tumor margin dose was 11 Gy (range 10-12 Gy). RESULTS The median follow-up duration was 48 months (range 6-156 months). All 35 patients had regular MRI follow-up examinations. Twenty tumors (57.1%) had a volume reduction of greater than 50%, 5 (14.3%) had a volume reduction of 15%-50%, 5 (14.3%) were stable in size (volume change < 15%), and 5 (14.3%) had larger volumes (all of these lesions were eventually resected). Four patients (11.4%) underwent resection within 9 months to 6 years because of progressive symptoms. One patient (2.9%) had open surgery for new-onset intractable trigeminal neuralgia at 48 months after GKRS. Two patients (5.7%) who developed a symptomatic cyst underwent placement of a cystoperitoneal shunt. Eight (66%) of 12 patients with pre-GKRS trigeminal sensory dysfunction had hypoesthesia relief. One hemifacial spasm completely resolved 3 years after treatment. Seven patients with facial weakness experienced no deterioration after GKRS. Two of 3 patients with serviceable hearing before GKRS deteriorated while 1 patient retained the same level of hearing. Two patients improved from severe hearing loss to pure tone audiometry less than 50 dB. The authors found borderline statistical significance for post-GKRS tumor enlargement for later resection (p = 0.05, HR 9.97, CI 0.99-100.00). A tumor volume ≥ 15 cm3 was a significant factor predictive of GKRS failure (p = 0.005). No difference in outcome was observed based on indication for GKRS (p = 0.0761). CONCLUSIONS Although microsurgical resection remains the primary management choice in patients with VSs, most VSs that are defined as having both a single dimension > 3 cm and a volume > 10 cm3 and tolerable mass effect can be managed satisfactorily with GKRS. Tumor volume ≥ 15 cm3 is a significant factor predicting poor tumor control following GKRS.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Huang CW, Tu HT, Chuang CY, et al. Gamma Knife radiosurgery for large vestibular schwannomas greater than 3 cm in diameter. J Neurosurg. 2017. PMID: 28707997. doi:10.3171/2016.12.JNS161530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。